There’s been a steady stream of news from the Alzheimer’s Association International Conference (AAIC) in Copenhagen, held July 12-17, 2014. The international summit brings together 4,500 professionals from 80 countries involved in Alzheimer’s treatment, patient care, and research.
Hundreds of vision disease experts came to Washington, D.C. this week for the 2014 Focus on Eye Health National Summit. BrightFocus and other vision advocacy groups help sponsor this annual event, which is organized by Prevent Blindness. Here are excerpts and insights from many of the featured speakers.
Exciting news travels from Washington University of St. Louis (WUSL), where two BrightFocus-funded Alzheimer’s researchers recently had their results published in major scientific journals. Both projects were directly funded by BrightFocus.
ARVO is made up of 12,750 vision and ophthalmology researchers from more than 80 countries (and growing). They're an eclectic group of clinical and basic researchers, including MDs, PhDs, and other degrees (optometrists, osteopaths, veterinarians, and scientists at the master's and undergraduate levels).
University of California, Irvine (UCI) researchers, led by BrightFocus researcher Frank M. LaFerla, PhD, have published positive findings from mice studies that suggest cell therapy slows down brain changes and symptoms linked to Alzheimer’s disease.
April 18, 2014
Donate to Cure Brain and Eye Diseases
Help end Alzheimer's, Macular Degeneration, and Glaucoma